or
forgot password
  • cancer clinical trials in santa monica, CA

  • Nutrition Intervention in Treating Women With Breast Cancer
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Breast Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    John Wayne Cancer Institute at Saint John's Health Center
    Santa Monica, California 90404
    Breast Cancer
    PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    Pacific Clinical Research
    Santa Monica, California 90404
    Prostate Cancer
    Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    UCLA Cancer Center
    Santa Monica, California 90404
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Santa Monica Urologic Medical Group
    Santa Monica, California 90404
    Bladder Cancer
    IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Brain and Central Nervous System Tumors
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Colorectal Cancer
    Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
    John Wayne Cancer Institute at Saint John's Health Center
    Santa Monica, California 90404
    Lung Cancer
    Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
    John Wayne Cancer Institute at Saint John's Health Center
    Santa Monica, California 90404
    Melanoma (Skin), Metastatic Cancer
    A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Esophageal Neoplasms, Hepatocellular Carcinoma, Colorectal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Neoplasms
    Vaccine Therapy in Treating Patients With Malignant Melanoma
    John Wayne Cancer Institute at Saint John's Health Center
    Santa Monica, California 90404
    Melanoma (Skin)
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Melanoma
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Neurofibromatosis Type 1, Sarcoma
    Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
    John Wayne Cancer Institute at Saint John's Health Center
    Santa Monica, California 90404
    Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer
    Chemotherapy and Bevacizumab in Treating Women With Invasive Breast Cancer
    Premiere Oncology
    Santa Monica, California 90404
    Breast Cancer
    Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
    The Angeles Clinic
    Santa Monica, California 90404
    Melanoma
    ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
    Premiere Oncology
    Santa Monica, California 90404
    Breast Cancer
    Trial of Dasatinib in Advanced Sarcomas
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Pacific Clinical Research
    Santa Monica, California 90404
    Prostate Cancer
    Brostallicin Clinical Trial for Myxoid Liposarcoma
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Myxoid Liposarcoma
    Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
    UCLA Center for East-West Medicine
    Santa Monica, California 90404
    Fatigue
    Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
    Doctor Susan Love Research Foundation
    Santa Monica, California 90403
    Breast Cancer
    Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Acute Promyelocytic Leukemia
    Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
    Premiere Oncology
    Santa Monica, California 90404
    Solid Tumors
    Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
    Premiere Oncology
    Santa Monica, California 90404
    Solid Tumors
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Melanoma
    A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma
    A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
    Site Reference ID/Investigator# 37463
    Santa Monica, California 90404
    Solid Tumors
    A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
    UCLA Health System
    Santa Monica, California 90404
    Non Small Cell Lung Cancer
    Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma
    Santa Monica Sarcoma Center
    Santa Monica, California 90403
    Hemangiosarcoma, Soft Tissue Sarcoma
    A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
    Premiere Oncology, A Medical Corporation
    Santa Monica, California 90404
    Advanced Nonhematologic Malignancies, Carcinoma, Basal Cell
    Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor, Tenosynovial Giant Cell Tumor
    Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
    Santa Monica
    Santa Monica, California 90403
    Soft Tissue Sarcoma
    A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Conventional Chondrosarcoma
    A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
    UCLA Santa Monica Hematology-Oncology
    Santa Monica, California 90404
    Solid Tumors
    Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
    Synta Pharmaceuticals Investigative Site
    Santa Monica, California 90404
    Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, Non-small Cell Lung Cancer Metastatic
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    Premiere Oncology
    Santa Monica, California 90404
    Metastatic Pancreatic Adenocarcinoma
    Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
    John Wayne Cancer Center
    Santa Monica, California 90404
    Cushing's Disease
    Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
    Santa Monica Oncology Center
    Santa Monica, California 90403
    Sarcoma, Alveolar Soft Part
    Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
    Investigational Site Number 840004
    Santa Monica, California 90403
    Hematopoietic Neoplasm
    Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
    UCLA Hematology-Oncology Santa Monica
    Santa Monica, California 90404
    Nonhematologic Malignancies, Lymphoma
    A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
    Investigational Site Number 840004
    Santa Monica, California 90403
    Neoplasm Malignant
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    Santa Monica Hematology/Oncology
    Santa Monica, California 90404
    Follicular Lymphoma
    Minimally Invasive Groin Dissection for Melanoma
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Melanoma
    Trial of pIL-12 Electroporation Malignant Melanoma
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Melanoma
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    UCLA Hematology Oncology
    Santa Monica, California 90404
    Metastatic Colorectal Cancer, Colorectal Cancer
    Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Metastatic Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
    Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
    Investigational Site Number 840004
    Santa Monica, California 90403
    Hematopoietic Neoplasm
    Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation.
    Sarcoma Oncology Center
    Santa Monica, California 90403
    Metastatic Soft Tissue Sarcoma
    A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
    UCLA Hematology Oncology
    Santa Monica, California 90404
    Primary Cutaneous Anaplastic Large Cell Lymphoma,, Mycosis Fungoides, Cutaneous T-Cell Lymphoma
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    John Wayne Cancer Institute
    Santa Monica, California 90404
    Cushing's Disease
    Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
    John Wayne Cancer Institute at Saint John's Health Center
    Santa Monica, California 90404
    Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma
    Phase 1 SAR650984 Combination With Lenalidomide
    Investigational Site Number 840004
    Santa Monica, California 90403
    Multiple Myeloma